Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Following earlier research supported by the SPCR, new evidence shows that point-of-care testing has made it possible for people on long-term oral anticoagulation therapy to monitor their own blood clotting time.

Patients on long-term anticoagulation therapy who test their own blood-clotting time from home and continue to be managed by their GP are significantly less likely to experience a thromboembolic event, according to Oxford University researchers. Read the press release.